Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children.

Block SL, Heikkinen T, Toback SL, Zheng W, Ambrose CS.

Pediatr Infect Dis J. 2011 Mar;30(3):203-7. doi: 10.1097/INF.0b013e3181faac7c.

PMID:
20935591
2.
3.

Influenza virus vaccines in children and their impact on the incidence of otitis media.

Rafei K.

Semin Pediatr Infect Dis. 2002 Apr;13(2):129-33. Review.

PMID:
12122951
4.

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.

Ambrose CS, Levin MJ, Belshe RB.

Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19. Review.

5.

Influenza vaccines in children.

Neuzil KM, Edwards KM.

Semin Pediatr Infect Dis. 2002 Jul;13(3):174-81. Review.

PMID:
12199613
6.

Impact of pneumococcal and influenza vaccines on otitis media.

Jenson HB, Baltimore RS.

Curr Opin Pediatr. 2004 Feb;16(1):58-60. Review.

PMID:
14758115
7.

Live attenuated influenza vaccine in children.

Ambrose CS, Walker RE, Connor EM.

Semin Pediatr Infect Dis. 2006 Oct;17(4):206-12. Review.

PMID:
17055372
8.

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.

Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM.

Expert Rev Vaccines. 2004 Dec;3(6):643-54. Review.

PMID:
15606348
9.

Live attenuated influenza virus vaccines: new options for the prevention of influenza.

Nichol KL.

Vaccine. 2001 Aug 14;19(31):4373-7. Review.

PMID:
11483261
10.
11.

Otitis media. A scholarly review of the evidence.

Pappas DE, Owen Hendley J.

Minerva Pediatr. 2003 Oct;55(5):407-14. Review.

PMID:
14608264
12.

Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.

Belshe RB, Mendelman PM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):745-67. Review.

PMID:
14753390
13.

Current status of live attenuated influenza virus vaccine in the US.

Belshe RB.

Virus Res. 2004 Jul;103(1-2):177-85. Review.

PMID:
15163507
14.

Adverse events associated with intranasal influenza vaccine in the United States.

Vasu N, Ghaffari G, Craig ET, Craig TJ.

Ther Adv Respir Dis. 2008 Aug;2(4):193-8. doi: 10.1177/1753465808093933. Review. Erratum in: Ther Adv Respir Dis. 2008 Dec;2(6):423.

PMID:
19124371
15.

Inactivated influenza virus vaccines in children.

Ruben FL.

Clin Infect Dis. 2004 Mar 1;38(5):678-88. Epub 2004 Feb 17. Review.

PMID:
14986252
16.

Rationale and approach to target children with asthma for annual influenza immunization.

Gaglani MJ.

Semin Pediatr Infect Dis. 2002 Apr;13(2):97-103. Review.

PMID:
12122959
17.

Are we ready for universal influenza vaccination in paediatrics?

Principi N, Esposito S.

Lancet Infect Dis. 2004 Feb;4(2):75-83. Review.

PMID:
14871631
18.

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Ambrose CS, Luke C, Coelingh K.

Influenza Other Respir Viruses. 2008 Nov;2(6):193-202. doi: 10.1111/j.1750-2659.2008.00056.x. Review.

19.

Prevention of acute otitis media using currently available vaccines.

Principi N, Baggi E, Esposito S.

Future Microbiol. 2012 Apr;7(4):457-65. doi: 10.2217/fmb.12.23. Review.

PMID:
22439723
20.

Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review.

Prutsky GJ, Domecq JP, Elraiyah T, Prokop LJ, Murad MH.

Pediatr Infect Dis J. 2014 Apr;33(4):e106-15. doi: 10.1097/INF.0000000000000200. Review.

PMID:
24632668

Supplemental Content

Support Center